Navigation Links
Marshall Edwards Announces First Patient Dosed in Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
Date:9/19/2011

SAN DIEGO, Sept. 19, 2011 /PRNewswire/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today that the first patient was dosed in the Company's Phase I clinical trial of its lead drug candidate ME-143 in patients with refractory solid tumors. The trial, conducted in collaboration with the Sarah Cannon Research Institute, is expected to enroll up to 24 patients with final data collected by the second quarter of 2012.

Fiscal Year End Conference Call

Marshall Edwards also announced that its management team will host a conference call with simultaneous webcast on Thursday, September 29, 2011, beginning at 5:00 p.m. Eastern time. Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present an overview of the Company; Robert Mass, MD, Chief Medical Officer, will discuss the Company's lead oncology drug candidates, including an update on the Phase I clinical trial of ME-143; and Thomas Zech, Chief Financial Officer, will provide a summary of the Company's fiscal year ended June 30, 2011 financial results.

To access the live call, please dial 866-800-8652 (toll-free) or 617-614-2705 (international), participant passcode 14784577. A replay of the call will be available approximately two hours after the conclusion of the call. To access the replay, please dial 888-286-8010 (toll-free) or 617-801-6888 (international), passcode 99793585. The conference call will also be webcast live and can be accessed at www.marshalledwardsinc.com/investor. Please connect several minutes prior to the start of the webcast to ensure adequate time for any software downloads that may be required.

About the Phase I Clinical Trial of ME-143

The Phase I trial of ME-143 was initiated earlier
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
2. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
3. Marshall Edwards to Host Annual Meeting of Stockholders
4. Marshall Edwards Receives Positive Response From NASDAQ
5. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
6. Marshall Edwards Announces Private Placement
7. Marshall Edwards Announces Closing of Asset Purchase Agreement With Novogen
8. Marshall Edwards Announces Publication of Pre-Clinical Studies in Pancreatic Cancer
9. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells
10. Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
11. Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014  Life Science Angels (LSA), a ... promising emerging biotech, medical device, genomics, diagnostic and ... Angel Investment Group in the U.S.  LSA was ... out of 370 angel groups analyzed nationwide based ... (connections), selection aptitude and brand recognition.  LSA was ...
(Date:9/30/2014)... Headquartered in Anaheim, California ... comprised of several specialized partners focused on leveraging the ... expertise of its team of professionals to improve the ... of more than 10 professional diagnostic tests for hospitals, ... 8 retail consumer tests is proud to announce an ...
(Date:9/30/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology, announced today that ... a finalist in the Diagnostics & Research Tools ... Awards, sponsored by CONNECT. CONNECT, a regional program that ... sciences products in San Diego County ...
Breaking Medicine Technology:Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3WholeHealth Products Announces The Discovery Of The "Autism And Fragile X" Microwell And Rapid Diagnostic Test 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3
... every clinical laboratory possesses one essential devicea centrifuge. ... refrigerated or non-cooled, but this apparatus, because of ... creating spin-induced high g-forces, has long been a ... For all this utility, these machines are true ...
... (EBV), which causes infectious mononucleosis (IM), is one of ... most people become infected with EBV sometime during their ... percent of adults between 35 and 40 years of ... the U.S., infection with EBV most often occurs during ...
Cached Medicine Technology:Bench-Top Centrifuges--Basic Tools for the Small Lab 2Bench-Top Centrifuges--Basic Tools for the Small Lab 3Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 2Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 3
(Date:9/30/2014)... 30, 2014 Sheridan Healthcare, ... the nation, today announced that Adam Blomberg, MD, ... division, will present at the Society for Healthcare ... Connections 2014 . The conference will be held ... Connections is a four-day conference that draws in ...
(Date:9/30/2014)... Visit Pam and Steve’s quiet home in the ... a loving couple facing the most monumental challenge of ... Steve was diagnosed with ALS – more commonly known ... the couple’s second wedding anniversary. Pam is now ... “Care, Support & ALS,” that’s part of the ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Houstonians seeking ... a place to visit on the Internet. Paul ... Houston’s most respected cosmetic surgeons, has launched a new ... the benefits of Botox Cosmetic services. The ... , According to the new website, Botox Cosmetic ...
(Date:9/30/2014)... Edward D. Buckingham, M.D., owner of the Buckingham ... be a director of a fellowship for the American ... program. The announcement came last week from the AAFPRS ... and Research Foundation for the AAFPRS fellowship program is ... postgraduate program in the world for the training of ...
(Date:9/30/2014)... TrailMyx.com —the country’s leading purveyor of ... Month: raw pumpkin seeds. , Pumpkin seeds—also known as ... protein, and valued by experts as an excellent source ... E. They are prized for their contributions to bone ... , Of course, pumpkin seeds are closely associated with ...
Breaking Medicine News(10 mins):Health News:Sheridan Healthcare Anesthesiologist to Present at Society for Healthcare Strategy & Market Development Conference 2Health News:Sheridan Healthcare Anesthesiologist to Present at Society for Healthcare Strategy & Market Development Conference 3Health News:Hospice Provides Care and Support to Patients and Family Caregivers with ALS 2Health News:Dr. Paul Vitenas Launches New Website To Showcase The Benefits Of Botox Cosmetic 2Health News:Dr. Paul Vitenas Launches New Website To Showcase The Benefits Of Botox Cosmetic 3Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 2Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 3Health News:TrailMyx.com Features October Flavor of the Month 2
... which is set to appear online later in ... the possible implications for traumatic brain injury (TBI) ... anti-inflammatory drugs (NSAIDS) as ibuprofen for chronic pain. ... humans have shown that long-term use of ibuprofen ...
... Children's Research Hospital it was found that a gene responsible ... also initiate leukemias. // ,This gene results in leukemia ... The discovery of the normal function of this gene suggests ... form might be used in leukemia patients with few serious ...
... certain genetic variation, along with inflammatory factors and smoking, ... macular degeneration, according to a study.// ,Age-related macular ... visual loss in the elderly of the Western world, ... play a role in AMD, and inflammation also may ...
... British schools are concerned that children in primary schools ... schools to tackle inappropriate// sexual behaviour. ,Children ... other in a rather "sexualised" manner with games such ... enough not to set alarm bells ringing. ...
... relied on humid air to relieve the barking cough and ... sends worried families to the emergency room. Now a new ... little medical benefit. ,“Typically you get people to ... you get them to boil a kettle in the room, ...
... that the elderly should not be barred from stroke rehabilitation ... the older a stroke victim, the less are the chances ... people over 80 years of age can recover as much ... the researchers studied 878 stroke survivors who received rehabilitation in ...
Cached Medicine News:Health News:Long-term Ibuprofen Therapy After Brain Injury Deteriorate Cognitive Abilities 2Health News:Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias 2Health News:Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias 3Health News:Genetic Variation Linked to Age-Related Macular Degeneration 2Health News:Humid Air is Little Help for Croup's Barking Cough 2Health News:Humid Air is Little Help for Croup's Barking Cough 3